Provides advanced downstream processing for fermentation-derived lipids with demonstrated commercial-scale readiness at TRL 9. Includes cost-effective solvent extraction and enzymatic lysis approaches, designed for scalability and flexibility across diverse industrial requirements. Processes show robustness across multiple feedstocks with high yields and reduced utility consumption. Additional pipeline innovations are at TRL 4, targeting further solvent reduction and improved enzymatic efficiency.
Specializes in downstream processing solutions for fermentation-derived lipids, delivering cost efficiencies and high yields. The technology has been validated at commercial scale with a Technology Readiness Level (TRL) of 9, demonstrating robustness across various feedstocks. Solutions include both solvent-based and enzymatic methods, offering flexibility to meet diverse industrial requirements. Additional development work is planned to further optimize performance.
Key features:
The technology is at TRL 9, indicating readiness for commercial deployment. Full-scale processes for lipid fermentation and extraction are operational at commercial scale, with a structured plan for further validation and improvements. Future validation phases will focus on optimizing feedstock-specific properties and integrating selected technologies into pilot-scale processes, preparing for pre-commercial scale demonstration.
C16 Biosciences specializes in developing sustainable ingredients through innovative biotechnologies, focusing on reducing environmental impact while delivering high-performance solutions for consumer goods.